vatalanib   Click here for help

GtoPdb Ligand ID: 5705

Synonyms: CGP 79787 | CGP-7978 | PTK787 | pynasunate | ZK-232934 | ZK222584
Compound class: Synthetic organic
Comment: Vatalanib is a potent and orally biovailable inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases [8].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 50.7
Molecular weight 346.1
XLogP 4.36
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES Clc1ccc(cc1)Nc1nnc(c2c1cccc2)Cc1ccncc1
Isomeric SMILES Clc1ccc(cc1)Nc1nnc(c2c1cccc2)Cc1ccncc1
InChI InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)
No information available.
Summary of Clinical Use Click here for help
Vatalanib progressed to Phase 3 clinical evaluation in a number of solid cancers. Click here to link to's complete list of registered vatalanib/PTK787 trials.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
This compound inhibits the induction of vascular endothelial growth factor (VEGF)-stimulated neo-angiogenesis which underpins and supports tumour growth.